Peptide Technologies Inc (PEPT) financial statements (2021 and earlier)

Company profile

Business Address 5348 VEGAS DRIVE #177
LAS VEGAS, NV 89108
State of Incorp. NV
Fiscal Year End March 31
SIC 2844 - Perfumes, Cosmetics, and Other Toilet Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
11/30/2014
11/30/2013
11/30/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3892108
Cash and cash equivalents3892108
Prepaid expense1239   
Prepaid expense and other current assets3
Other undisclosed current assets124   51 
Total current assets:25198215111
Noncurrent Assets
Intangible assets, net (including goodwill)48133
Intangible assets, net (excluding goodwill)48133  
Other noncurrent assets   3 
Other undisclosed noncurrent assets    (51)54
Total noncurrent assets:48135(51)54
Other undisclosed assets   (3)  
TOTAL ASSETS:255106154065
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:359274269689 731
Accounts payable115383837  
Accrued liabilities23151042  
Employee-related liabilities221221221580  
Other undisclosed accounts payable and accrued liabilities   30 731
Due to related parties13113167   
Other undisclosed current liabilities     84
Total current liabilities:490405336689 815
Noncurrent Liabilities
Other undisclosed noncurrent liabilities20670    
Total noncurrent liabilities:20670    
Other undisclosed liabilities   1101,751 
Total liabilities:6964753367991,751815
Stockholders' equity
Stockholders' equity attributable to parent, including:(441)(370)(321)(795)(1,700)(750)
Common stock127127127156 149
Additional paid in capital777777732188148105
Accumulated deficit(1,345)(1,274)(1,180)(106)(106)(106)
Other undisclosed stockholders' equity attributable to parent   (1,034)(1,743)(898)
Total stockholders' equity:(441)(370)(321)(795)(1,700)(750)
TOTAL LIABILITIES AND EQUITY:2551061545165

Income statement (P&L) ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
11/30/2014
11/30/2013
11/30/2012
Revenues2  0  
Financial services revenue 0  
Other income2  
Cost of revenue
(Other Cost of Operating Revenue)
(0)     
Gross profit:1  0  
Operating expenses(91)92(49)(25)(34)(17)
Other undisclosed operating loss (183)    
Operating loss:(90)(92)(49)(25)(34)(17)
Nonoperating income (expense)
(Foreign Currency Transaction Gain (Loss), before Tax)
4(1)(0)6 (1)
Interest and debt expense151 (4)4 
Loss from continuing operations before equity method investments, income taxes:(71)(92)(50)(22)(29)(19)
Other undisclosed loss from continuing operations before income taxes   (445)  
Loss before gain (loss) on sale of properties:(71)(92)(50)(468)(29)(19)
Other undisclosed net income126186991,328  
Net income (loss):559450860(29)(19)
Other undisclosed net loss attributable to parent(159)(187)(99)  (641)
Net income (loss) available to common stockholders, diluted:(104)(94)(50)860(29)(660)

Comprehensive Income ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
11/30/2014
11/30/2013
11/30/2012
Net income (loss):559450860(29)(19)
Comprehensive income (loss), net of tax, attributable to parent:559450860(29)(19)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: